Treatment of advanced heart failure

Area of Science:

• Cardiology
• Internal Medicine
• Public Health

Background:

• Rising incidence of chronic heart failure (CHF) leads to increased morbidity, mortality, and societal financial burden.
• Advances in CHF therapy have significantly improved patient survival, reduced hospitalizations, and enhanced quality of life.
• Optimizing medical regimens for CHF patients presents an opportunity to potentially decrease healthcare expenditures.

Purpose of the Study:

• To review current management strategies for severe heart failure.
• To emphasize the importance of etiology identification and patient education in CHF management.
• To discuss the role of pharmacotherapy and other interventions in the treatment of heart failure.

Main Methods:

• Literature review of current heart failure management guidelines and therapeutic options.
• Analysis of the impact of improved therapies on patient survival and healthcare utilization.
• Discussion of diagnostic approaches to determine the etiology and extent of myocardial dysfunction.

Main Results:

• Improved therapies have led to prolonged survival and reduced hospitalizations in heart failure patients.
• Angiotensin-converting enzyme inhibitors are central to pharmacotherapy after etiological diagnosis.
• Non-transplant surgical and medical therapies form the primary treatment strategy for most severe heart failure cases.

Conclusions:

• Effective management of severe heart failure requires etiological diagnosis and patient education.
• Rational medical regimens, including ACE inhibitors, are crucial for optimizing patient outcomes.
• A comprehensive treatment strategy combining medical and surgical interventions is essential for managing the growing burden of heart failure.